A detailed history of Bbr Partners, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Bbr Partners, LLC holds 60,000 shares of ACRS stock, worth $173,400. This represents 0.01% of its overall portfolio holdings.

Number of Shares
60,000
Previous 60,000 -0.0%
Holding current value
$173,400
Previous $66,000 1.52%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.92 - $1.44 $55,200 - $86,400
60,000 New
60,000 $74,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $193M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Bbr Partners, LLC Portfolio

Follow Bbr Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbr Partners, LLC with notifications on news.